BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38694509)

  • 21. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
    Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
    Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma.
    Wu S; Gong Y; Chen J; Zhao X; Qing H; Dong Y; Li S; Li J; Wang Z
    Biol Direct; 2022 Jul; 17(1):19. PubMed ID: 35902970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.
    Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA
    BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway.
    Zhao Z; Qin X
    Sci Rep; 2020 Oct; 10(1):16729. PubMed ID: 33028966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition.
    Huang H; Li T; Meng Z; Zhang X; Jiang S; Suo M; Li N
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
    Dong S; Ding Z; Zhang H; Chen Q
    Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719
    [No Abstract]   [Full Text] [Related]  

  • 28. Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression.
    Feng X; He S; Chen Y; Zhang L
    Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
    Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
    Front Immunol; 2022; 13():959967. PubMed ID: 36177002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Hub Genes for Early Diagnosis and Predicting Prognosis in Colon Adenocarcinoma.
    Xu S; Liu D; Cui M; Zhang Y; Zhang Y; Guo S; Zhang H
    Biomed Res Int; 2022; 2022():1893351. PubMed ID: 35774271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis.
    Liu Y; Li C; Dong L; Chen X; Fan R
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32936304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis.
    Miao Z; Liu S; Xiao X; Li D
    Gene; 2020 Jun; 743():144604. PubMed ID: 32213297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
    Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D
    Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLOD3 Is Associated with Immune Cell Infiltration and Genomic Instability in Colon Adenocarcinoma.
    Deng X; Pan Y; Yang M; Liu Y; Li J
    Biomed Res Int; 2021; 2021():4714526. PubMed ID: 34239923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and clinical validation of metastasis-associated biomarkers based on large-scale samples in colon-adenocarcinoma.
    Gu L; Liu Y; Jiang C; Sun L; Zhou H
    Pharmacol Res; 2020 Oct; 160():105087. PubMed ID: 32683036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatics Analysis of
    Wu L; Tian X; Du H; Liu X; Wu H
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening key long non-coding RNAs in early-stage colon adenocarcinoma by RNA-sequencing.
    Liu JX; Li W; Li JT; Liu F; Zhou L
    Epigenomics; 2018 Sep; 10(9):1215-1228. PubMed ID: 30182733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High miR-31-5p expression promotes colon adenocarcinoma progression by targeting TNS1.
    Mi B; Li Q; Li T; Liu G; Sai J
    Aging (Albany NY); 2020 Apr; 12(8):7480-7490. PubMed ID: 32315285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.